BDBM402636 5-{[(1S,2R)- or (1R,2S)-2- amino-5,5- difluorocyclohexyl]amino}- N-[3-(difluoromethyl)-1- methyl-1H-pyrazol-4- yl]pyrazolo[1,5- a]pyrimidine-3- carboxamide::US10329294, Example 210

SMILES Cn1cc(NC(=O)c2cnn3ccc(N[C@H]4CC(F)(F)CC[C@H]4N)nc23)c(n1)C(F)F

InChI Key InChIKey=JNVJEPGPCYEEHD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 402636   

TargetInterleukin-1 receptor-associated kinase 4(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM402636(US10329294, Example 210 | 5-{[(1S,2R)- or (1R,2S)-...)
Affinity DataIC50: 1nMAssay Description:The kinase activity of IRAK4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent